Northpond Ventures — Full Portfolio

Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.

BiotechEmeryville, US

WBWarner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)PMPeter Maag(Executive Officer, Director)in

Co-investorsBABain Capital Life SciencesVIVida VenturesWEWestlake Village BioPartnersGIGilead SciencesINInsight PartnersKLKleiner Perkins+3 more

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXZXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)RCRob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in

Board seatSKSharon Kedar· per SEC Form D

Co-investorsARARCH Venture Partners6 6 Dimensions CapitalALAlly Bridge GroupAPApplied VenturesKIKilonova CapitalPUPura Vida Investments+3 more

Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research.

BiotechDeep TechHealthtech

DIDonald Ingber(Founder)inDLDaniel Levner(Co-Founder & CTO)inJCJim Corbett(CEO, Board Member)inLELorna Ewart(Chief Scientific Officer)in

Co-investors+N+ND CapitalALALS Investment FundALAlumni VenturesALAlwyn CapitalFOFourth RealmSTStray Dog Capital+4 more

Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings.

AI & Machine LearningBiotechHealthtechMedical DevicesBurlingame, US

TSTim Sweeney(Co-Founder and CEO)inPKPurvesh Khatri(Founder)inJRJONATHAN ROMANOWSKY(Co-Founder)inTimothy Sweeney(Founder)

BoardKENNETH BAHK(Director)MICHAEL RUBIN(Director)

Co-investorsKHKhosla VenturesINInitiate Venture PartnersMAMarram VenturesOSOSF VenturesSTStartXDFDFJ

Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.

AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB

Michael B. Brenner(Founder)Chris Buckley(Founder)MCMark Coles(Founder)inSRSoumya Raychaudhuri(Founder)DADavid A. Tuveson(Founder)Lindsey Rolfe(Chief Medical Officer)in

Co-investorsGVGV (Google Ventures)SVSV Health InvestorsFOForbionJOJohnson & Johnson Innovation – JJDCJJJJDC

Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US

WHWilliam Hagstrom(Founder and Chairman)inDBDoug Biehn(President and CEO)in

Co-investorsSASandbox IndustriesSESection 32BLBlue Venture FundsECEcho Health VenturesHIHikma VenturesINIntermountain Health+4 more

OMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs.

BiotechDeep TechDigital HealthHealthtechMedical DevicesOxford, GB

PDProfessor Dame Carol Robinson(Founder and Chair of Scientific Advisory Board)ILIdlir Liko(Founder)inJHJonathan Hopper(Vice President, Platforms and Founder)inHYHsin Yung (Jason) Yen(Founder)inRDRos Deeganin

Co-investorsGVGV (Google Ventures)OXOxford Science EnterprisesSASanofi Ventures

QbDVision provides a software platform designed to address digital transformation challenges in pharmaceutical and biotech manufacturing, helping companies manage compliance, quality, and process development.

BiotechCloud ComputingEnterprise SoftwareHealthtechSaaSAustin, US

YSYash Sabharwal(President, CEO, Co-Founder)inRSRyan Shillington(CTO, CISO, Co-Founder)in

Co-investorsS3S3 VenturesCACartmell VenturesCRCREATE HEALTH VENTURES

Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.

AI & Machine LearningBiotechDeep TechCambridge, US

TKTuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)SCSamuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)

Co-investorsLILifeforce CapitalMAMagnetic VenturesTATaiho Ventures, LLCDODolby Family Ventures

VitalBio develops the VitalOne, a diagnostic device that delivers comprehensive lab-grade blood test results in minutes from a small blood sample, using robotics, biochemistry, computer vision, and microfluidics.

BiotechDigital HealthMedical Devices

VNVasu Nadella(Founder)in

Co-investorsNENext VenturesINInovia CapitalLALachy GroomMAMarc BenioffSASam Altman191955 Capital+8 more

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)TLTerry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in

Co-investorsARARCH Venture PartnersM M VenturesILIllumina VenturesNONovalis LifeSciences

En Plus One Bio develops synthesis and manufacturing technology for RNA therapeutics, focused on producing high-purity long RNA with higher cycle efficiencies and novel chemical modifications.

BiotechDeep TechWatertown, US

DADaniel Ahlstedt(Executive Officer, Director)inJRJonathan Rittichier(Founder)inDaniel Wiegand(Founder)George M. Church(Founder)

BoardALAndrew Lee(Director)in

Board seatPMPaxton Major· per SEC Form D

Co-investorsBRBreakout VenturesCOCoatue Management

IsoPlexis offers the Cell Analysis Suite (CAS), software for its Beacon optofluidic platform that lets researchers design, automate, and analyze functional live single-cell workflows.

AI & Machine LearningBiotechDeep TechMedical DevicesSaaSNew Haven, US

Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)inRaj KhakharinJing Zhouin

BoardDaniel Wagner(Director)

Board seatSKSharon Kedar· per SEC Form D

Co-investorsCOConnecticut InnovationsALAlly Bridge GroupIRIronwood CapitalSPSpring Mountain Capital

64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics.

BiotechDeep TechMedical Devices

Co-investorsBOBoxGroupFIFirst Round CapitalFIFifty YearsFUFuture VenturesLILifeforce CapitalRERefactor Capital+1 more

64x Bio develops cell-line engineering and production technologies to overcome manufacturing bottlenecks in advanced and next-generation therapies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

LRLexi Rovner(CEO, Co-founder, Board of Directors)inAlexis Rovner(Founder)Ryan GallagherEmily Hawkins(Head of Talent)George Church, PhD(Co-founder, Scientific Advisory Board)David Thompson, PhD(Co-founder, Scientific Advisory Board)

Co-investorsFIFifty YearsFUFuture VenturesG G VenturesLILifeforce CapitalRARaptor GroupY Y Combinator+8 more

Andson Biotech develops analytical tools for the analysis of biotherapeutics, aimed at supporting the discovery and development of biologic drugs.

BiotechDeep TechHealthtechAtlanta, US

MCMason Chilmonczyk(Founder)inJFJim Filippini(Executive Officer)inRob Grier(Vice President of Operations)

BoardAndrei Fedorov(Director)Thomas O'Brien(Director)James Ross(Director)

Co-investorsGAGaingelsPHPhase Two VenturesY Y CombinatorEQEquity Trust CompanyMCMcKesson VenturesMEMerck Global Health Innovation Fund+1 more

Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.

BiotechDeep TechHealthtechEmeryville, US

DLDan Lin-Arlow(Founder)inSPSebastian Palluk(Founder)inDHDaniel Hillel Lin-Arlow(Executive Officer, Director)JTJason T. Gammack(Executive Officer, Director)inDaniel Lin-Arlow(Founder)Jared Ellefson(Founder)

Co-investorsCACarbon SiliconCECerberus VenturesDADauntless VenturesFIFifty YearsJUJude GomilaMEMetaplanet+14 more

Aro is a Brazilian technology platform that connects users with over 40 regulated credit partners to find personal loans, payroll (consignado CLT) loans, phone-collateral loans, and credit for people with negative credit records.

AI & Machine LearningB2B MarketplacesFintech

Co-investorsNONorte VenturesONOnevc Venture Partners Llc1717SigmaCOCowen Healthcare Investments

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.

BiotechHealthtechPhiladelphia, US

KOKaryn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)

BoardElizabeth Anderson(Director)BPBruce Peacock(Director)

Co-investorsAVAvego BioScience CapitalHEHealthCapAGAgent CapitalBIBiotechnology Value FundCOCowen Healthcare InvestmentsJOJohnson & Johnson Innovation – JJDC

Camp4 is a biotechnology company focused on genetic research and neurology, leveraging expertise in genomics and neuroscience for therapeutic development.

AI & Machine LearningBiotech

Leonard Zon(Founder)Richard Young(Founder)

BoardChristopher Walsh, MD, PhD(Scientific Advisor)

Co-investors5A5AM VenturesANAndreessen HorowitzFLFlucas Ventures

QbDVision develops a Digital CMC (Chemistry, Manufacturing, and Controls) platform that captures structured product and process data to support end-to-end product lifecycle management from R&D through commercial manufacturing.

AI & Machine LearningBiotechSaaSAustin, US

Yashvinder Sabharwal(Executive Officer, Director)Ryan Shillington(Executive Officer, Director)

Co-investorsATATX Venture Partners

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US

PFPaul Flook(Executive Officer, Director)inGregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)inAxel Scherer(Director)

BoardJKJustin Klein(Director)in

Co-investorsADAdjuvant CapitalGLGlobal BrainMOMoore Venture PartnersNENew Enterprise Associates (NEA)WIWindham Capital PartnersDODomain Associates+2 more

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.

BiotechDeep TechHealthtechHatfield, US

Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)BMBrian McVeigh(Executive Officer, Director)in

BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)

Co-investorsNENew Enterprise Associates (NEA)4B4BIO CapitalAMAmgen VenturesHAHatteras Venture PartnersJDJDRF T1D FundTATakeda Ventures+1 more

Culture Biosciences operates bioreactors as a service for biotech companies, running fermentation experiments and developing manufacturing processes for customers that engineer organisms to produce therapeutics, materials, fuels, and foods.

AI & Machine LearningBiotechCloud ComputingFoodTechHealthtechNew MaterialsSan Francisco, US

WPWill Patrick(CEO)inMBMatt Ball(CTO)inJonathan Meed(Senior Software Engineer)Satshabad Khalsa(Software Engineer)Andre Castillo(Director of Hardware Operations, Manufacturing and Quality)Fre Tachea(Director of Fermentation)

Co-investorsCOCompoundCUCultivian Sandbox VenturesDCDCVC (Data Collective)GRGRIDS CapitalHEHemisphere Ventures LLCTETeam Builder Ventures+20 more

Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings.

AI & Machine LearningDigital HealthHealthtechMedical DevicesEdinburgh, US

CMChristopher McGhee(Founder)in

Co-investorsLRLRVHealthMMMMC VenturesOSOSF VenturesPEPerot JainSESection 32

Paradigm Health combines technology and services to re-engineer clinical trials, integrating with healthcare provider organizations to improve patient enrollment and access to care.

BiotechDigital HealthHealthtechColumbus, US

Tim Bowen(Executive Officer, Promoter)DBDave Billiter(Executive Officer, Director, Promoter)inSASimon Arkell(Executive Officer, Promoter)in

BoardMSMark Shary(Director)inJeffrey Elton(Director)

Co-investorsSEService Provider CapitalSISierra VenturesTATamarind HillRERev1 Ventures

Eleanor Health is an outpatient addiction treatment program that delivers remote evidence-based care for substance use disorder, including medication-assisted treatment and counseling.

Digital HealthHealthtechMental HealthWaltham, US

DNDr. Nzinga Harrison(Chief Medical Officer and Co-founder)CPCorbin Petro(Executive Officer, Director)Srishti Mirchandani(Executive Officer)in

BoardDWDavid Whelan(Director)inSonny Goyal(Director)KSKurt Sheline(Director)in

Co-investorsECEcho Health VenturesGEGeneral CatalystRERethink ImpactTOTown Hall VenturesWAWarburg Pincus

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.

BiotechDigital HealthHealthtechMedical DevicesMadison, US

Jonathan Oliner(Executive Officer)inMAManeesh Arora(Founder)inMichelle B. Arora(Director)Terrence P. Brady(Executive Officer)

Co-investorsARARCH Venture PartnersSASands Capital Ventures

San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.

Co-investorsARARCH Venture PartnersDEDecheng CapitalALAlexandriaDEDeerfield Management CompanyGVGV (Google Ventures)NANan Fung Life Sciences

General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.

Deep TechHealthtechMedical Devices

Co-investorsOMOMX VenturesPAPaladin Capital GroupGEGenoa VenturesVEVertical Venture Partners

BiotechPortola Valley, US

Lena Wu(Executive Officer, Director)Erik Gentalen(Director)Michael Rubin(Director)

BoardJRJenny Rooke(Director)in

Co-investorsGEGenoa VenturesHEHemisphere Ventures LLCVEVertical Venture Partners

Isolere Bio develops affinity-based reagents and purification platforms for concentrating and purifying viral vectors used in gene therapy, including adeno-associated viruses and lentiviruses.

Advanced ManufacturingBiotechDeep TechNew MaterialsResearch Triangle Park, US

Michael LaBreck(Co-founder)Michael Dzuricky(Director of Advanced R&D)

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.

BiotechDeep TechHardwareCambridge, US

CBCullen Buie(Founder; Board Observer)inPGPaulo Garcia(Founder)inMCMichael Chiu(Chief Executive Officer)in

BoardPMPaxton Major(Director)inADAnn DeWitt(Director)inPaul Wotton(Director)

Co-investorsBABantam GroupHOHorizons VenturesMAMassVenturesSESelvedge VentureTBTBD AngelsTETelegraph Hill Partners+2 more

Modern Systems Talk (MST) publishes content and insights on technology topics including system architecture, cloud computing, automation, AI, cybersecurity, and digital transformation.

Media & Entertainment

Co-investorsAGAgate Medical Investments LPSCSCP Vitalife PartnersFOForbionGVGV (Google Ventures)SVSV Health Investors

Douglas Hanahan(Founder)Gideon Bollag(Founder)Joseph Schlessinger(Founder)

Co-investorsLOLongitude CapitalMEMenlo Ventures

Opt Industries engineers advanced materials using digital photolithography to create structured materials with precise microstructure control, enabling functional properties across applications from high-speed interconnects to fluid handling.

Advanced ManufacturingDeep TechNew MaterialsMedford, US

JOJifei Ou(Founder)in

Co-investorsCRCrosslink CapitalGAGaingelsGRGrit VenturesTHThe E14 FundBLBlumberg CapitalGRGradient Ventures

Ori develops expandable-unit technology for multifamily real estate, enabling hotel-to-housing conversions and ground-up developments that increase unit density while maintaining livability.

Construction TechHardwareImpact & Social GoodPropTech

Hasier Larrea(Founder)

Co-investorsINIngka InvestmentsPRPresidio VenturesTHThe E14 FundAMAmadeus Capital PartnersDEDelin VenturesEPEpisode1+4 more

ORI provides an integrated business planning platform for supply chain professionals, combining demand planning, S&OP, S&OE, data analytics, and long-term planning in one tool.

AI & Machine LearningLogistics & Supply ChainSaaS

BSBrant Slade(Founder)in

Co-investorsKIKickstartAMAmadeus Capital PartnersDEDelin VenturesKHKhosla VenturesNONovalis LifeSciencesOCOctopus Ventures+2 more

Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.

Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices

Co-investorsAMAmadeus Capital PartnersDEDelin VenturesKIKindred CapitalNONovalis LifeSciencesOCOctopus VenturesPUPuhua Capital

Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information.

AI & Machine LearningDigital HealthHealthtechCambridge, US

MRMaya R. Said(Founder and CEO)inOsama Rahma(Founder)inMRMaya R. Said, Sc.D.(Founder and CEO)

BoardAJAndrea Jackson(Director)inDavid Fleshman(Director)David Auckland(Director)

Co-investorsASAsset Management CompanyHEHealthX VenturesSISierra VenturesASAsset Management Ventures

Phia is an AI shopping assistant that compares prices across the web and secondhand marketplaces so shoppers can build their closet at the best price.

New York, US

SKSophia Kianni(Founder)inPGPhoebe Gates(Founder)in

BoardACAnnie Case(Director)in

Co-investorsCOCold Start VenturesDUDuke Capital PartnersKLKleiner PerkinsMEMento vcNONotable CapitalSCScribble Ventures+2 more

Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics.

AI & Machine LearningBiotechData & InfrastructureSaaSMarlborough, US

ANAjit Nagral(CEO & Chairman)inGGGeoff Gerhardt(Executive Officer, Promoter)inVPVinayak Purohit(Executive Officer)in

BoardCMCharles M. Hazard, Jr.(Director)inAJAndrea Jackson(Director)inRohit Khanna(Director)

Co-investorsFLFlybridge Capital Partners

The company develops diagnostics and biological sample collection devices, including a rapid sickle-cell test, supporting infectious disease detection and genomic, metabolomic, and microbiome research.

BiotechHealthtechMedical DevicesCambridge, US

RDRahul Dhanda(Executive Officer, Director)inJCJames Collins(Director)DWDavid Walt(Director)in

BoardIRIssi Rozen(Director)in

Co-investorsCACatalio Capital Management, LPGAGaingelsILIllumina VenturesCACatalio Capital ManagementGOGood VenturesGVGV (Google Ventures)+1 more

SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

JPJoe Peterson(Co-founder)John Cole(Co-founder)TPTushar Pandey(Co-founder)inSSStacey Stevens(Executive Officer, Director)in

BoardVCVikram Chaudhery(Director)inLCLucy Coassin(Director)

Co-investorsAVAV8 VenturesGEGenoa VenturesKLKleinmuntz AssociatesXCXcellerant VenturesGEGENERAL INCEPTION

Slingshot Biosciences makes synthetic cell mimics used as standardized reference controls for flow cytometry and cell-based assays.

Emeryville, US

JKJeff Kim(Founder)inAdam Wieschhaus(Director)Ronald J. Silberman(Director)

BoardCRCorey Ritter(Director)in

Co-investorsARARCH Venture PartnersANAnterra Capital

AgTechEmeryville, US

EDEric Davidson(Director)inTBTravis Bayer(Director)inPBPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)ALAdam Litle(Executive Officer, Director)inDNDerek Norman(Director)in

Co-investorsCACavallo VenturesCUCultivian Sandbox VenturesFAFall Line CapitalFOFootPrint CoalitionS2S2G InvestmentsLELeaps by Bayer+2 more

SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions.

BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesSydney, AU

ATAlison Todd(Co-founder)EMElisa Mokany(Co-founder)in

Co-investorsTETenmile

Developing off-the-shelf hematopoietic stem cell therapies for severe diseases.

Co-investorsOROrbiMedAIAisling Capital

StrideBio develops gene therapies based on its STRIVE AAV capsid platform, targeting people with life-threatening diseases.

BiotechHealthtechDurham, US

AAAravind Asokan(Director)inMAMavis Abjandje-McKenna(Director)RSRichard Smith(Executive Officer)inPatrick Ritschel(Executive Officer, Director, Promoter)

Co-investorsHAHatteras Venture PartnersPOPontifax Venture CapitalABAbingworthDEDe Novo Ventures

Palo Alto, US

Jonathan Hirsch(Founder)Glenn Winokur(Founder)Tony Loeser(Founder)

BoardJKJohn Kuelper(Director)inCPChamath Palihapitiya(Director)inGary Kurtzman, M.D.(Director)

Co-investorsASAscension VenturesGEGE VenturesSOSocial Capital Partnership

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.

AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US

DGDaniel G. Gibson(Executive Officer)inTRTodd R. Nelson(Executive Officer, Director)EEEric Esser(Executive Officer)inWilliam F. Snider(Director)ALAndrea L. Jackson(Director)inChristine A. Tsingos(Director)

Co-investorsNONovalis LifeSciences

BiotechCambridge, US

Shawn Marcell(Executive Officer, Director)BLBen Linden(Executive Officer)inDavid Yu Zhang(Director)Peng Yin(Director)

BoardAdam Wiechhaus(Director)

Co-investorsILIllumina Ventures

Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment.

BiotechHealthtechMedical DevicesAustin, US

TERESA MCROBERTS(Executive Officer)inPLPAUL LAMMERS, MD, MSc(Executive Officer, Director)inJIJON IRVIN(Executive Officer)in

BoardDANIEL JANSE(Director)JURGEN ECKHARDT(Director)ELIZABETH WILLIAMS(Director)

Co-investorsATATEM Capital FundB B Capital GroupB4B4 CapitalCHCheckmate Capital Group LLCLELeaps by BayerOCOceanpine Capital

Uptime Health provides operational tools and preventive maintenance plans to healthcare practices to reduce downtime and ensure regulatory compliance.

Enterprise SoftwareHealthtechSaaSBoston, US

William Olsen(Executive Officer, Director)JPJinesh Patel(Executive Officer, Director)in

BoardJohn Huysmans(Director)

Co-investorsBABantam GroupC2C2 VenturesCACaduceus Capital PartnersDIDIAKLKluz VenturesOVOverline+8 more

Vestaron develops peptide-based insecticides derived from naturally-occurring peptides such as those found in spider venom, produced through fermentation, offering new modes of action for crop protection.

AgTechBiotechCleantechClimate TechNew MaterialsKalamazoo, US

GKGlenn King(Founder)inJEJuan Estupinan(Executive Officer, Director)inDDDawn de los Santos(Executive Officer)inRobert Kennedy(Executive Officer)Nancy Newman(Executive Officer)inJohn C. Sorenson(Executive Officer, Director)

Co-investorsARArgonautic VenturesCACavallo VenturesCUCultivian Sandbox VenturesENEndeavor8ISiSelect FundMIMichigan Capital Network+4 more

Co-investorsSOSocium Ventures

Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients.

AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US

Lewis Williams(Co-founder & CEO)inRusty Williams(Founder)Antonin de Fougerolles(Director)Momo Wu(Director)Stella Xu(Director)Alexis Ji(Director)

Co-investorsFIFirst Spark Ventures, LlcPAPandect BioventuresILIllumina Ventures